Egypt - English - EDA (Egyptian Drug Authority)

hexal ag germany - coated tablet - 60 mg

Egypt - English - EDA (Egyptian Drug Authority)

hexal ag germany - tablet - 100 mg

Egypt - English - EDA (Egyptian Drug Authority)

hexal ag germany - tablet - 25 mg

Singapore - English - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - ondansetron hydrochloride dihydrate 2.495 mg/ml eqv ondansetron - injection, solution - 2.495mg (2mg) - ondansetron hydrochloride dihydrate 2.495 mg/ml eqv ondansetron 2 mg/ml

Malta - English - Medicines Authority

ebewe pharma gmbh nfg. kg mondseestrasse 11, 4866 unterach, austria - gemcitabine - concentrate for solution for infusion - gemcitabine - antineoplastic agents

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - linezolid - solution for infusion - 2 milligram(s)/millilitre - other antibacterials; linezolid - other antibacterials - it is indicated for the treatment of community acquired pneumonia and nosocomial pneumonia when known or suspected to be caused by susceptible gram positive bacteria and for the treatment of complicated skin and soft tissue infections

European Union - English - EMA (European Medicines Agency)

sandoz pharmaceuticals d.d. - nelarabine - precursor t-cell lymphoblastic leukemia-lymphoma - antineoplastic agents - nelarabine is indicated for the treatment of patients with t-cell acute lymphoblastic leukaemia (t-all) and t-cell lymphoblastic lymphoma (t-lbl) whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. due to the small patient populations in these disease settings, the information to support these indications is based on limited data.,

European Union - English - EMA (European Medicines Agency)

sandoz pharmaceuticals d.d. - topotecan - ovarian neoplasms; uterine cervical neoplasms; small cell lung carcinoma - antineoplastic agents - hycamtin capsules are indicated as monotherapy for the treatment of adult patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.topotecan is indicated for the treatment of patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy.hycamtin capsules are indicated as monotherapy for the treatment of adult patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.